Skip to evidence report

ASPC.adipocyte_capillary_interface: Studies — page 6

How association tiers are defined — cell–trait and gene–trait

SCREATE tier definitions supplied by the atlas curator. This methods note explains the prepared classifications; it does not recompute or change any report scores or tiers.

Cell–trait tiers

Cell–trait links
Identify cell types whose regulatory activity is associated with a trait’s genetic signal.
Required for Specific or Relevant
The ICE-CREAM score derived from the mean metacell Z score must be ≥ 5.39, with BOTH nominal and adjusted ICE-CREAM P values ≤ 0.05.
Specific (Tier 1)
Also meets all cell-set enrichment analysis (CSEA) criteria in at least one tested comparison: nominal P ≤ 0.05 AND adjusted P ≤ 0.05 AND normalized enrichment score (NES) ≥ 1, all in that comparison. This indicates that trait-associated activity is concentrated in this cell type relative to the tested background.
Relevant (Tier 2)
Meets the ICE-CREAM requirements but not the additional CSEA criteria. The cell type may share trait-associated activity with other cell types.
Interpretation and report values
CSEA is cell-set enrichment analysis, analogous to gene-set enrichment analysis but using sets of cells along a ranked list of ICE-CREAM scores. The eligibility score derived from the mean metacell Z score is not the displayed mean IC score. Do not infer a tier from the displayed mean, its descriptive Significance column, or a single CSEA summary value. Reports preserve prepared tiers; Other means an available association outside Specific/Relevant, and unavailable is not zero or proof of biological irrelevance.
Meta traits and individual traits
Use the prepared tier for the exact meta trait or individual trait. A meta trait’s Best child CSEA FDR is the lowest available child FDR, not a combined or meta-trait significance test. Its displayed mean child NES is descriptive, not a new CSEA test. These summaries must not be used to reconstruct or override the meta-trait tier.

Gene–trait priorities (variant–tCRE–gene evidence)

Variant–tCRE–gene links
Candidate variants connect to genes through overlapping promoters or distal transcribed cis-regulatory elements (tCREs) linked to gene promoters by the Activity-by-Contact (ABC) model.
Required genetic support
The variant belongs to a purity-passing SuSiE credible set OR qualifies for Borzoi rescue. Borzoi rescue requires BOTH a variant-causality score ≥ 0.3 AND linkage disequilibrium with the lead variant of r² ≥ 0.2.
Required cellular support
The overlapping promoter has positive tCRE activity OR the distal element has a passing cell-specific ABC link to the gene, in a Specific or Relevant cell subtype (L1S) or fine-grained state (L2). BOTH genetic and cellular support are required for High or Medium priority.
High priority
Among records meeting both minimum requirements, High requires a genetic score ≥ 0.5 AND a Layer 1 correlation > 0.3 between tCRE activity and the trait’s cellular profile across cell subtypes.
Medium priority
Meets both minimum requirements but not one or both additional High thresholds. The genetic score is the higher of the SuSiE posterior inclusion probability (PIP) and the Borzoi variant-causality score.
Same-record evidence and aggregation
Each priority requires genetic and cellular evidence supporting the SAME variant–tCRE–gene record. Do not combine thresholds or evidence from different records to create a qualifying link. A gene receives the highest priority observed among its supporting records. A tCRE summary uses supporting records for that exact tCRE, not every trait of its linked genes. Separately displayed aggregate scores do not relax the same-record rule.
Limits of interpretation
A priority is candidate-association evidence, not proof of a causal variant, causal gene, causal cell type or treatment efficacy. Missing evidence is unavailable, not zero. MAGMA −log10(P), displayed credibility scores, cellular-context scores and G/C tier codes must not be substituted for these eligibility tests; use the provided records and their documented fields.

State · 1,040 full-atlas cells · all tissues.

Marker genes and cell annotation · Open this population in Cell Browser →

ICE-CREAM (IC) is −log10(P) from a permutation test. An IC score of 3 corresponds to an unadjusted P value of 0.001; 5.5 is the multiple-testing-corrected significance threshold across all metacells. The Significance categories are Significant for IC > 5.5, Nominal for 3 ≤ IC ≤ 5.5, and Nonsignificant for IC < 3. These reports display mean IC scores across full-atlas populations, not the UMAP sample. The categories apply to the displayed scores: a cell-group mean or an average across individual traits is descriptive and is not itself a newly tested P value or a new multiple-testing correction. All scores are retained. Enrichment is not proof of causality or treatment efficacy.

Rows 5,001–6,000 of 12,313; ranked by score descending. Equal values use name/identifier order.

Studies ranked for ASPC.adipocyte_capillary_interface
#Trait / studyIndividual trait IDMean IC score
5001Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T381ECGA0003810.52
5002DTI TBSS FA Posterior thalamic radiation RGCST903844080.52
5003Cholesteryl Esters in Small LDLGCST904995860.52
5004Left hippocampal volume (body)GCST902679480.52
5005GBA1 levelsGCST904232620.52
5006T1 FIRST volume L HippGCST903839900.52
5007Omega-3 fatty acids to total fatty acids percentageGCST905020900.52
5008DTI TBSS L3 Superior fronto-occipital fasciculus RGCST903845660.52
5009Placental weight (fetal genotype, adjusted for sex and gestational age)GCST902751890.52
5010Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T160ECGA0001600.52
5011Vitamin and mineral supplements - Multivitamins +/- minerals | MedicationUKBB000009000.52
5012Concentration of small HDL particlesGCST904994640.52
5013IDP dMRI ProbtrackX L3 str lGCST900043230.52
5014Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T340ECGA0003400.52
5015Phospholipids in medium VLDLGCST904990250.52
5016Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T148ECGA0001480.52
5017SCARA3 levelsGCST904278560.52
5018Triglycerides to Total Lipids in Medium HDL percentageGCST904986820.52
5019Working memoryGCST905031160.52
5020C8B levelsGCST904685030.52
5021Triglycerides to Total Lipids in Very Large HDL percentageGCST905005080.51
5022Total lipids in very large VLDLGCST905006140.51
5023DTI autoptx L3 slf l tractGCST903852140.51
5024Free cholesterol in large HDLGCST904977800.51
5025LRIG1 levelsGCST904697940.51
5026Frequency of tenseness / restlessness in last 2 weeks | Mental healthUKBB000002670.51
5027ENO2/PRSS27 ratioGCST903146660.51
5028ERBB4/F3 ratioGCST903146900.51
5029Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T204ECGA0002040.51
5030CD2AP/USP8 ratioGCST903137840.51
5031CLIP2/DAB2 ratioGCST903141240.51
5032TNFRSF1A levelsGCST900120150.51
5033Average weekly beer plus cider intake | AlcoholUKBB000000820.51
5034Left-hemisphere dorsal attention network to right-hemisphere somatomotor network white-matter structural connectivityGCST903026950.51
5035Carcinoma in situ of breast, intraductal (controls excluding all cancers)FING000002400.51
5036Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T187ECGA0001870.51
5037Bursitis (PheCode 726.3)GCST904762400.51
5038GIMAP7 levelsGCST904693450.51
5039Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T95ECGA0000950.51
5040TriglyceridesGCST0007580.51
5041IDP dMRI TBSS MD Cingulum hippocampus LGCST900040640.51
5042Right ventricular peak atrial filling rateGCST902681190.51
5043GGACT levelsGCST904693330.51
5044Milk type used - Skimmed | DietUKBB000004700.51
5045ITGA5/VCAM1 ratioGCST903152060.51
5046IL22 levelsGCST904695820.51
5047Monounsaturated fatty acids to total fatty acids percentageGCST904991110.51
5048Left-hemisphere dorsal attention network to left-hemisphere salience/ventral attention network white-matter structural connectivityGCST903026900.51
5049IDP dMRI TBSS ICVF Superior longitudinal fasciculus LGCST900043680.51
5050DTI TBSS L2 Retrolenticular part of internal capsule RGCST903844960.51
5051GSTT2B levelsGCST904694150.51
5052Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T100ECGU0001000.51
5053Total lipids in medium VLDL (UKB data field 23503)GCST902696000.51
5054SERPINA4 levelsGCST904705840.51
5055Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T387ECGU0003870.51
5056CD40LG/GP6 ratioGCST903138220.50
5057Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T305ECGA0003050.50
5058IDP T1 FAST ROIs R cerebellum XGCST900025890.50
5059F-deep fried food liking (derived food-liking factor)GCST900947530.50
5060KLB levelsGCST904696930.50
5061IDP dMRI TBSS ICVF Uncinate fasciculus LGCST900043720.50
5062ExotropiaGCST905727370.50
5063DAPP1/SDC4 ratioGCST903143990.50
5064Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T240ECGU0002400.50
5065Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T83ECGA0000830.50
5066Plasma mannonate* levels in chronic kidney diseaseGCST902654790.50
5067DTI autoptx L3 ilf l tractGCST903852070.50
50681-(1-enyl-palmitoyl)-2-palmitoleoyl-GPC (P-16:0/16:1) levelsGCST902000700.50
5069IDP dMRI ProbtrackX FA atr rGCST900039280.50
5070TXNL1 levelsGCST904709930.50
5071Sleep disorders (PheCode 327)GCST904758230.50
5072Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T223ECGU0002230.50
5073MPIG6B/PLXNA4 ratioGCST903154830.50
5074CAMK1D levelsGCST902405560.50
5075Cholesteryl esters in medium HDL (UKB data field 23569)GCST902696660.50
5076Triglycerides x anxiety interaction (2df test)GCST905706770.50
5077F5 levelsGCST904464660.50
5078CETN2/PRTFDC1 ratioGCST903140300.50
5079GPIHBP1 levelsGCST904693900.50
5080Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T449ECGA0004490.50
5081Osteoarthritis, localized (PheCode 740.1)GCST904762540.50
5082DNA methylation-estimated granulocyte proportionsGCST900142870.50
5083SERPINB9 levelsGCST904705930.50
5084NGRN levelsGCST904700450.50
5085Polyunsaturated fatty acids to total fatty acids percentageGCST905026480.50
5086Cholesterol in Small LDLGCST904995550.50
5087IDP dMRI TBSS FA Splenium of corpus callosumGCST900038810.50
5088Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T302ECGA0003020.50
5089APOA1 levelsGCST904971220.50
5090Hyphaema and other vascular disorders of iris and ciliary bodyFING000006470.50
5091Triacylglycerol_58:7_[M+NH4]1+ levelsGCST900605640.50
5092Medication for pain relief, constipation, heartburn - Paracetamol | MedicationUKBB000004590.50
5093Saturated fatty acids to total fatty acids percentageGCST904999580.50
5094FAM13A levelsGCST904691810.50
5095T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 65)GCST903208840.50
5096CCN2/MGLL ratioGCST903137140.50
5097Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T382ECGA0003820.50
5098Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T337ECGU0003370.50
5099Right-hemisphere somatomotor network to right-hemisphere control network white-matter structural connectivityGCST903027920.49
5100Triglycerides to total lipids in very large HDL percentage (UKB data field 23633)GCST902697300.49
5101Snoring | SleepUKBB000007840.49
5102IDP dMRI ProbtrackX ICVF slf rGCST900043970.49
5103IDP dMRI ProbtrackX FA ptr rGCST900039450.49
5104EGLN1/PIK3AP1 ratioGCST903146190.49
5105Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T301ECGA0003010.49
5106Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T297ECGU0002970.49
5107CCL17/THPO ratioGCST903136890.49
5108Concentration of chylomicrons and extremely large VLDL particlesGCST900930470.49
5109Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T147ECGA0001470.49
5110Blood cell traits latent factor 7 (white cell)GCST905592490.49
5111Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T181ECGU0001810.49
5112IL4R levelsGCST904695980.49
5113IGSF8/NECTIN2 ratioGCST903151400.49
5114IL18BP levelsGCST904695640.49
5115HippSubfield lh volume Whole-hippocampal-bodyGCST900026870.49
5116White blood cell countGCST900259850.49
5117DTI autoptx L2 str l tractGCST903851890.49
5118Docosahexaenoic acid to total fatty acids percentageGCST905022810.49
5119Left-hemisphere salience/ventral attention network to right-hemisphere dorsal attention network white-matter structural connectivityGCST903027140.49
5120Triglyceride levels in chylomicrons and extremely large VLDLGCST900930500.49
5121Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T332ECGU0003320.49
5122CPXM1 levelsGCST904688490.49
5123Phospholipids in IDLGCST904976280.49
5124RILP/RWDD1 ratioGCST903157780.49
5125Phospholipids in VLDL (UKB data field 23412)GCST902695090.49
5126AcneFING000000100.49
5127Concentration of HDL particles (UKB data field 23430)GCST902695270.49
5128IDP dMRI TBSS OD Superior corona radiata LGCST900044270.49
5129CDKN2D/MANF ratioGCST903139890.49
5130PPIE levelsGCST902422170.49
5131PPP2R5A levelsGCST904703060.49
5132IDP dMRI TBSS ISOVF External capsule RGCST900045090.48
5133Phospholipids to total lipids ratio in small HDLGCST900929530.48
5134Triglycerides to Total Lipids in Small VLDL percentageGCST904999340.48
5135COL18A1/RETN ratioGCST903141700.48
5136CirrhosisGCST900186060.48
5137FSTL3 levelsGCST904692720.48
5138RPN1 levelsGCST902409640.48
5139Total cholesterol levelsGCST902396750.48
5140X-21286 levelsGCST902005620.48
5141SLURP1 levelsGCST904706740.48
5142FAM3B levelsGCST904691860.48
5143Total lipid levels in HDLGCST900928250.48
5144Free Cholesterol to Total Lipids in Large HDL percentageGCST904977900.48
5145aparc-DKTatlas rh volume fusiformGCST900028980.48
5146Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T151ECGU0001510.48
5147MEGF9/OXT ratioGCST903154190.48
5148Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T214ECGU0002140.48
5149MPHOSPH8/PSRC1 ratioGCST903154780.48
5150Reticulocyte countGCST900259720.48
5151ARTN levelsGCST904683720.48
5152PTPRC levelsGCST904703800.48
5153T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 30)GCST903208490.48
5154Calculus of kidney and ureterFING000002360.48
5155CD300LG/CLEC14A ratioGCST903138010.48
5156FGFBP1 levelsGCST904692300.48
5157IL18BP/THBD ratioGCST903151560.48
5158Treatment or medication use - ezetimibe (UKB data field 20003_1141192736)GCST900425410.48
5159RP2 levelsGCST904704930.48
5160SNCA levelsGCST902402580.47
5161Enthesopathies of lower limb, excluding footFING000005090.47
5162Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T248ECGA0002480.47
5163Total lipids in large HDLGCST904978180.47
5164AZU1 levelsGCST904684080.47
5165total cholesterol (mean, inv-norm transformed)GCST904764240.47
5166Isolated hypothyroxinemia in pregnancyGCST904351980.47
5167X-12216 levelsGCST902004830.47
5168Polyunsaturated fatty acids to saturated fatty acids ratioGCST905021680.47
5169BCAN/MOG ratioGCST903134800.47
5170wg lh intensity-contrast lateraloccipitalGCST900038020.47
5171PneumoniaGCST900186810.47
5172SIGLEC7 levelsGCST904706350.47
5173IDP dMRI ProbtrackX ISOVF str lGCST900045480.47
5174Optic disc areaGCST0040760.47
5175LGALS9/SIGLEC1 ratioGCST903153230.47
5176Linoleic acid to total fatty acids percentageGCST905023320.47
5177Saturated fatty acids levelsGCST905026590.47
5178CD84/GP1BA ratioGCST903139130.47
5179Lymphocyte countGCST900187420.47
5180Phospholipid levels in very large VLDLGCST900930240.47
5181Allergic conjunctivitisFING000000670.47
5182Citrate levelsGCST900928130.47
5183RNASE6 levelsGCST904704790.47
5184PFKFB2 levelsGCST904702150.47
5185Cholesterol to total lipids in very large HDL percentage (UKB data field 23630)GCST902697270.47
5186aseg rh number HolesBeforeFixingGCST900026470.47
5187GP2/LGALS8 ratioGCST903149610.47
5188Total lipids in large VLDLGCST904982160.47
5189Glycerophosphorylcholine (GPC) levelsGCST901996290.47
5190THPO levelsGCST904708570.47
5191Triglycerides in small LDL (UKB data field 23550)GCST902696470.47
5192CPA4 levelsGCST904688380.47
5193Total bile acid levels in pregnancyGCST904541980.47
5194Cholesteryl Esters in Medium VLDLGCST904989280.46
5195Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T190ECGU0001900.46
5196Free cholesterol in medium LDLGCST904987740.46
5197RBFOX3 levelsGCST904704320.46
5198KITLG levelsGCST904696910.46
5199Drinks usually with meals in current drinkers (yes and it varies vs no) (UKB data field 1618)GCST901329250.46
5200Orange juice likingGCST900948060.46
5201Monounsaturated fatty acids to total fatty acids percentageGCST905023840.46
5202SLIT2 levelsGCST904706680.46
5203Triacylglycerol_51:2_[M+NH4]1+ levelsGCST900604970.46
5204Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T345ECGA0003450.46
5205Cholesterol levels in very large VLDLGCST900930160.46
5206Right-hemisphere default mode network to amygdala white-matter structural connectivityGCST903028490.46
5207DCTN1/SCAMP3 ratioGCST903144330.46
5208TIMP3 levelsGCST904708710.46
5209AGRN/CRIM1 ratioGCST903132000.46
5210LSIL lesion of the cervix uteri, vagina or vulvaFING000007330.46
5211Glycated hemoglobin levelsGCST905664240.46
5212Major depressive disorder (ICD-10 coded)GCST0059030.46
5213IDP dMRI ProbtrackX L1 str lGCST900042690.46
5214ENPP2 levelsGCST904691150.46
5215Triglycerides to total lipids ratio in small HDLGCST900929550.46
5216Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T341ECGA0003410.46
5217Joint pain (confirmatory factor analysis Factor 14)GCST903093480.46
5218TMSB10/TXNRD1 ratioGCST903159250.46
5219FAS levelsGCST904277020.46
5220Triacylglycerol_54:5_[M+NH4]1+ levelsGCST900605390.46
5221aparc-a2009s rh volume G+S-subcentralGCST900030020.46
5222CTSF/CTSV ratioGCST903143130.46
5223OGA levelsGCST904701170.46
5224Inpatient record format - UK HES Inpatients (2017 format) | Summary AdministrationUKBB000003650.46
5225Elevated prostate specific antigen [PSA] (PheCode 796)GCST904762770.46
5226PNMA1 levelsGCST904702760.46
5227BAIAP2 levelsGCST904684190.46
5228PMVK/PRDX5 ratioGCST903156940.46
5229PDGFB levelsGCST904701890.46
5230ICD10 N83.0, N83.1, N83.2: Ovarian cyst, including follicular cyst, corpus luteum cyst, and other/unspecified ovarian cystGCST904542150.46
5231LEP levelsGCST0033680.46
5232ITGB1BP2/SKAP2 ratioGCST903152190.46
5233LRRFIP1 levelsGCST904698050.46
5234Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T213ECGU0002130.46
5235Total lipid levels in very large HDLGCST900930100.46
5236Cholesteryl ester levels in very large VLDLGCST900930180.46
5237Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T379ECGA0003790.46
5238SELP levelsGCST904705690.46
5239CCL13/CCL17 ratioGCST903136740.46
5240Phosphate levels (UKB data field 30810)GCST904680940.46
5241Calcium levelsGCST900187310.46
5242DKK3 levelsGCST904689980.46
5243Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T209ECGA0002090.46
5244Plasma pregnenetriol sulfate* levels in chronic kidney diseaseGCST902658660.46
5245Other diseases of oesophagus | Diseases of oesophagus, stomach and duodenumUKBB000006060.46
5246HAVCR1 levelsGCST900120410.46
5247Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T202ECGU0002020.46
5248aparc-Desikan rh volume fusiformGCST900028070.45
5249Fasting plasma glucoseGCST902977870.45
5250LILRB2 levelsGCST904697770.45
5251Percentage of fucosylated structures (with bisecting GlcNAc) in total neutral plasma glycans (GP80)GCST906687580.45
5252Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T346ECGU0003460.45
5253DTI TBSS MD Superior longitudinal fasciculus LGCST903846130.45
5254REG1A levelsGCST904704470.45
5255LTBR/SIRPB1 ratioGCST903153390.45
5256CES3 levelsGCST904687200.45
5257Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T500ECGU0005000.45
5258Benign neoplasm of major salivary glandsFING000001570.45
5259Treatment/medication code - atenolol | MedicationsUKBB000008420.45
5260Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T74ECGA0000740.45
5261IDP dMRI TBSS ICVF Fornix cres+Stria terminalis RGCST900043650.45
5262MUC13 levelsGCST904699630.45
5263SFTPD levelsGCST904706140.45
5264aparc-Desikan lh area TotalSurfaceGCST900030730.45
5265Glycoprotein acetyls levelsGCST904973280.45
5266IL6ST levelsGCST904696030.45
5267Total lipid levels in very large VLDLGCST900930220.45
5268Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T135ECGA0001350.45
5269C19ORF12 levelsGCST904684830.45
5270STX4 levelsGCST904707720.45
5271ABL1 levelsGCST904681900.45
5272Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T291ECGU0002910.45
5273Other retinal disordersFING000010940.45
5274PTH1R levelsGCST904703710.45
5275Saturated fatty acids to total fatty acids percentageGCST905022070.45
5276T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 4)GCST903208230.45
5277DTI TBSS L3 Posterior corona radiata LGCST903845510.45
5278CD5/IL16 ratioGCST903138610.45
5279Total fatty acid levelsGCST905027230.45
5280SPARC levelsGCST904707180.45
5281DCTN1 levelsGCST904689580.45
5282Disorders of vitreous bodyFING000004650.45
5283NELL2 levelsGCST904700270.45
5284Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T1ECGA0000010.45
5285Right ventricular peak ejection rateGCST902681200.45
5286Total Ceramide levelsGCST900258170.44
5287Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T177ECGU0001770.44
5288Congenital malformations of the circulatory systemFING000003400.44
5289Cholesteryl Esters in Medium LDLGCST904987380.44
5290Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T96ECGA0000960.44
5291IDP dMRI TBSS L3 Posterior corona radiata LGCST900041980.44
5292TRIM5 levelsGCST904709700.44
5293Phosphatidylcholine_38:5_[M+H]1+/Phosphatidylethanolamine_41:5_[M+H]1+/Phosphatidate_43:6_[M+NH4]1+ levelsGCST900603950.44
5294MIF levelsGCST904699060.44
5295VSTM2B levelsGCST904710560.44
5296ABL1/DNMBP ratioGCST903131490.44
5297MVK/SERPINE1 ratioGCST903155050.44
5298Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T350ECGA0003500.44
5299Atrial fibrillation and flutterFING000001260.44
5300ENO3 levelsGCST904691110.44
5301Cancer of bronchus; lung (PheCode 165.1)GCST904755730.44
5302Right-hemisphere limbic network to thalamus white-matter structural connectivityGCST903028270.44
5303Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T338ECGU0003380.44
5304Gestational [pregnancy-induced] oedema and proteinuria without hypertensionFING000005720.44
5305Omega-6 fatty acids to total fatty acids percentageGCST905025290.44
5306IDP dMRI ProbtrackX L3 cgc lGCST900043040.44
5307Free cholesterol levels in medium HDLGCST900928960.44
5308DIABLO/PDGFB ratioGCST903144680.44
5309Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T51ECGA0000510.44
5310SNAP23/TXLNA ratioGCST903158570.44
5311Indolebutyrate levelsGCST901997590.44
5312Congenital malformations of heart and great arteriesFING000003360.44
5313DTI autoptx L2 ilf l tractGCST903851800.44
5314Triglyceride levels in very large VLDLGCST900930260.44
5315Principal component-derived dietary pattern 32GCST901330370.44
5316DTI autoptx L2 unc r tractGCST903851920.44
53172-hydroxyisobutyrate levelsGCST902435390.44
5318IDP dMRI ProbtrackX FA slf rGCST900039470.44
5319Spread type - Never/rarely use spread | DietUKBB000007940.44
5320CPE levelsGCST904688410.44
5321NECTIN4/SPINK5 ratioGCST903155340.44
5322Cholesteryl esters in very large VLDLGCST905005520.44
5323Degree of unsaturationGCST905001620.44
5324SUSD1/THPO ratioGCST903158990.44
5325FAM3C levelsGCST904691870.44
5326Alcohol abuse, main dg (more control exclusions)FING000000490.43
5327High cholesterolGCST904681340.43
5328High light scatter reticulocyte countGCST900023850.43
5329IDP dMRI TBSS FA Superior fronto-occipital fasciculus LGCST900039200.43
5330Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T93ECGA0000930.43
5331Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T412ECGU0004120.43
5332Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T254ECGU0002540.43
5333CDH6/NTRK2 ratioGCST903139620.43
5334ENTPD5 levelsGCST902410240.43
5335Free cholesterol in large VLDLGCST904981850.43
5336Chronic ulcer of leg or foot (PheCode 707.2)GCST904762180.43
5337Right-hemisphere control network to thalamus white-matter structural connectivityGCST903028360.43
5338DKK1 levelsGCST904689970.43
5339IDP dMRI ProbtrackX ISOVF cgc lGCST900045290.43
5340Cholesteryl ester_16:0_[M+NH4]1+ levelsGCST900602110.43
5341Phospholipid levels in chylomicrons and extremely large VLDLGCST900930480.43
5342MAP2K6/TBL1X ratioGCST903153780.43
5343PALM levelsGCST904701540.43
5344wg rh intensity-contrast rostralanteriorcingulateGCST900038520.43
5345AmygNuclei rh volume Accessory-Basal-nucleusGCST900026600.43
5346DTI TBSS L1 External capsule LGCST903844610.43
5347Hippocampal subfield left CA3 volume (head)GCST902679410.43
5348Total lipids in very small VLDLGCST905008100.43
5349Peak expiratory flow (PEF) | SpirometryUKBB000006380.43
5350Reticulocyte countGCST900024050.43
5351Right-hemisphere limbic network to hippocampus white-matter structural connectivityGCST903028310.43
5352Concentration of very large VLDL particlesGCST900930230.43
5353Left-hemisphere limbic network to hippocampus white-matter structural connectivityGCST903027400.43
5354Cholesterol in Small VLDLGCST904997500.43
5355Cholesterol in Large HDLGCST904977190.43
5356Mixed conductive and sensorineural hearing lossFING000008270.43
5357KLK1 levelsGCST904697020.43
5358aparc-a2009s rh volume S-postcentralGCST900030650.43
5359YAP1 levelsGCST904710860.43
5360T1 FreeSurfer DKT lh superiortemporal thicknessGCST903842520.43
5361DTI autoptx MD ilf l tractGCST903852340.43
5362Total lipids in medium HDL (UKB data field 23566)GCST902696630.43
5363GP1BB levelsGCST904693810.43
5364Ulcerative enterocolitisFING000013910.43
5365Cardiomyopathy (PheCode 425)GCST904759490.43
5366Right-hemisphere somatomotor network to right-hemisphere somatomotor network white-matter structural connectivityGCST903027880.43
5367Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T157ECGU0001570.43
5368DTI TBSS L3 Posterior corona radiata RGCST903845500.43
5369Ulcerative proctitisFING000013930.43
5370Cholesterol esters in very small VLDLGCST905007400.43
5371Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T331ECGU0003310.43
5372DTI autoptx MD unc r tractGCST903852460.43
5373CD226 levelsGCST904686090.43
5374HDL x low social support interaction (2df test)GCST905706690.42
5375Osteoarthrosis, localized, primary (PheCode 740.11)GCST904762550.42
5376T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 5)GCST903205680.42
5377FHIT/GLOD4 ratioGCST903148170.42
5378SSC4D levelsGCST904707470.42
5379CCL11/CCL7 ratioGCST903136730.42
5380IDP dMRI TBSS ISOVF Superior longitudinal fasciculus RGCST900045170.42
5381Cholesterol to total lipids ratio in medium HDLGCST900928930.42
5382Polyunsaturated fatty acids to monounsaturated fatty acids ratioGCST905025710.42
5383ConstipationFING000003480.42
5384Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T286ECGU0002860.42
5385TNFSF12 levelsGCST902748460.42
5386Ever felt worried, tense, or anxious for most of a month or longer | AnxietyUKBB000002150.42
5387Free cholesterol in VLDL (UKB data field 23420)GCST902695170.42
5388ADGRE5 levelsGCST904682380.42
5389DTI TBSS L2 FornixGCST903844810.42
5390Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T357ECGA0003570.42
5391EGF/PPIB ratioGCST903146120.42
5392Type 1 diabetes with neurological manifestations (PheCode 250.14)GCST904756640.42
5393IL1R1 levelsGCST904695710.42
5394Polyunsaturated fatty acids to monounsaturated fatty acids ratioGCST905025540.42
5395Muscular dystrophyFING000008480.42
5396Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T343ECGU0003430.42
5397Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T258ECGA0002580.42
5398Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T296ECGU0002960.42
5399Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T346ECGA0003460.42
5400Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T447ECGA0004470.42
5401Ceramide (d16:1/24:0) levelsGCST900252660.42
5402DTI TBSS L3 Sagittal stratum RGCST903845540.42
5403T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 44)GCST903208630.42
5404GZMA/GZMH ratioGCST903150080.42
5405Left-hemisphere visual network to caudate white-matter structural connectivityGCST903026630.42
5406CDH1 levelsGCST904686700.42
5407QPCT levelsGCST904704010.42
5408Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T406ECGU0004060.42
5409PLXNA4/USP8 ratioGCST903156900.42
5410Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T2ECGA0000020.42
54113-methyl-2-oxobutyrate levelsGCST901996770.42
5412Phospholipids to total lipids in chylomicrons and extremely large VLDL percentage (UKB data field 23579)GCST902696760.42
5413IL7 levelsGCST904696060.42
5414Eicosenoylcarnitine (C20:1) levelsGCST902001480.42
5415Lysoalkylphosphatidylcholine (O-20:0) levelsGCST900241930.42
5416CC2D1A/STIP1 ratioGCST903136650.42
5417aseg rh intensity Cerebellum-CortexGCST900037810.42
5418Triglycerides in HDLGCST904974670.42
5419BA-exvivo rh area BA45GCST900032290.42
5420Linoleic acid to total fatty acids percentageGCST905020170.42
5421Cholesterol in Medium VLDLGCST904989090.42
5422aparc-Desikan lh area rostralmiddlefrontalGCST900030990.42
5423Retinal thickness (functional principal component 3)GCST904557230.42
5424Glycerate levelsGCST902002900.42
5425ICA1/TANK ratioGCST903151120.42
5426Triglycerides in HDLGCST904974640.42
5427Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T132ECGA0001320.42
5428Glutamine levels (UKB data field 23461)GCST902695580.41
5429ERBB3/IL1R2 ratioGCST903146890.41
5430Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T444ECGA0004440.41
5431CDKN2D levelsGCST904686850.41
5432IDP dMRI TBSS ICVF Posterior corona radiata RGCST900043530.41
5433NAGK levelsGCST904699950.41
5434Insomnia (standard GWA)GCST902672860.41
5435T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 4)GCST903205670.41
5436Free cholesterol levels in medium HDLGCST901326790.41
5437Drinks usually with meals in current drinkers (yes vs no) (UKB data field 1618)GCST901329260.41
5438Monounsaturated fatty acid levelsGCST904990940.41
5439Bullous keratopathyFING000002310.41
5440THTPA levelsGCST904708600.41
5441Lysophosphatidylcholine (22:0) [sn2] levelsGCST900241760.41
5442Spread type: Flora Pro-Active/Benecol (UKB data field 1428_2)GCST901329570.41
5443Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T164ECGA0001640.41
5444CX3CL1 levelsGCST902412040.41
5445Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T114ECGU0001140.41
5446Urine 5-acetylamino-6-amino-3-methyluracil levels in chronic kidney diseaseGCST902646740.41
5447HDL x depression interaction (2df test)GCST905706670.41
5448AGER levelsGCST904682520.41
5449aparc-a2009s rh volume G-cuneusGCST900030090.41
5450CKAP4/LTBR ratioGCST903140740.41
5451Phospholipids in very small VLDLGCST905008510.41
5452aseg lh volume Cerebellum-White-MatterGCST900026180.41
5453CTSC/PLA2G15 ratioGCST903143110.41
5454Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T94ECGA0000940.41
5455ECG, heart rate | ECG during exerciseUKBB000002040.41
5456Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T351ECGA0003510.41
5457BCAN/NPTXR ratioGCST903134820.41
5458ICAM1 levelsGCST904694980.41
5459Left-hemisphere salience/ventral attention network to right-hemisphere default mode network white-matter structural connectivityGCST903027180.41
5460Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T473ECGU0004730.41
5461Hearing aid useGCST900447740.41
5462Treatment or medication use - atorvastatin (UKB data field 20003_1141146234)GCST900423760.41
5463Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T59ECGA0000590.41
5464aparc-Desikan lh volume parstriangularisGCST900027870.41
5465SRC levelsGCST904707410.41
5466Phospholipids to Total Lipids in Small HDL percentageGCST904994940.41
5467Encounter for long-term (current) use of anticoagulants (PheCode 286.2)GCST904757990.41
5468CST3 levelsGCST904688940.41
5469aparc-DKTatlas rh area parsopercularisGCST900032810.41
5470Experiencing mood swingsGCST0069440.41
5471Cholesterol to total lipids in medium HDL percentage (UKB data field 23640)GCST902697370.41
5472Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T378ECGA0003780.41
5473SLITRK2 levelsGCST904706700.41
5474HDLBP levelsGCST900875330.41
5475DTI TBSS MD Sagittal stratum LGCST903846030.41
5476Congenital iodine-deficiency syndrome/hypothyroidismFING000003280.41
5477Free cholesterol to total lipids ratio in chylomicrons and extremely large VLDLGCST900930450.41
5478Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T156ECGU0001560.40
5479SELPLG levelsGCST900120460.40
5480Cholesteryl Esters in Large VLDLGCST904981460.40
5481Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T266ECGA0002660.40
5482Phosphatidylcholine_40:6_[M+H]1+/Phosphatidylethanolamine_43:6_[M+H]1+ levelsGCST900604460.40
5483Interpolated Age of participant when operation took place | OperationsUKBB000003700.40
5484Concentration of very large HDL particles (UKB data field 23551)GCST902696480.40
5485IDP dMRI TBSS ICVF External capsule RGCST900043590.40
5486CTSZ/HSPG2 ratioGCST903143180.40
5487Cholesteryl esters to total lipids ratio in small LDLGCST900929590.40
5488APP/EGF ratioGCST903133220.40
5489Triglycerides to Total Lipids in Medium HDL percentageGCST904986890.40
5490EczemaGCST904681260.40
5491Total lipid levels in chylomicrons and extremely large VLDLGCST900930460.40
5492Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T308ECGU0003080.40
5493Dihomo-linoleoylcarnitine (C20:2) levelsGCST902001440.40
5494Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T355ECGA0003550.40
5495DTI autoptx L2 ilf r tractGCST903851810.40
5496Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T488ECGA0004880.40
5497Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T257ECGA0002570.40
5498HBEGF/LAT2 ratioGCST903150320.40
5499ThalamNuclei lh volume PuAGCST900027200.40
5500GRP levelsGCST902412420.40
5501Other and unspecified disorders of vitreous bodyFING000009340.40
5502Leucine levelsGCST900928910.40
5503Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T120ECGA0001200.40
5504PZP levelsGCST904703990.40
5505Free cholesterol levels in chylomicrons and extremely large VLDLGCST900930440.40
5506SHBG levelsGCST904706220.40
5507PDGFB/PTPN6 ratioGCST903156250.40
5508AXL/GAS6 ratioGCST903134190.40
5509Free cholesterol in IDLGCST904975640.40
5510PDGFA/SERPINE1 ratioGCST903156180.40
5511Monounsaturated fatty acids to total fatty acids percentageGCST905023890.40
5512Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T349ECGA0003490.40
5513IDP dMRI TBSS MD Body of corpus callosumGCST900040300.40
5514Non-oily fish intake | DietUKBB000005250.40
5515DTI autoptx FA atr l tractGCST903851140.40
5516Antihypertensive medication - note that there are other indicationsFING000000970.40
5517Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T354ECGA0003540.40
5518Triglycerides to total lipids ratio in medium HDLGCST900929030.40
5519Marzipan likingGCST900947970.40
5520Basal metabolic rate (UKB data field 23105)GCST904681590.40
5521Coffee difference likingGCST900947380.40
5522Other haemoglobinopathiesFING000010530.40
5523Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T255ECGA0002550.40
5524GKN2 levelsGCST900894130.40
5525Left eye overall retinal pigment epithelium thicknessGCST906720320.40
5526Phospholipids in medium HDL (UKB data field 23567)GCST902696640.40
5527NOTCH2 levelsGCST904700660.40
5528Cholesterol in Medium HDLGCST904984920.40
5529Cooked vegetables consumptionGCST901329770.40
5530Omega-6 fatty acids levelsGCST904991770.40
5531ADGRG2/NRCAM ratioGCST903131860.40
5532Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T353ECGA0003530.40
5533total creatine kinase (mean, inv-norm transformed)GCST904764130.39
5534Phospholipids in small LDLGCST904996730.39
5535THY1/TNFRSF21 ratioGCST903159190.39
5536Cholesterol to Total Lipids in Large HDL percentageGCST904977320.39
5537STMN3 levelsGCST902428940.39
5538DHEAS levelsGCST901996730.39
5539Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T377ECGA0003770.39
5540Fresh fruit intake | DietUKBB000002720.39
5541FAM3D levelsGCST904691880.39
5542Alcohol usually taken with meals (UKB data field 1618)GCST901330040.39
5543Cholesteryl Esters to Total Lipids in Small HDL percentageGCST904994030.39
5544Platelet countGCST900023580.39
5545Deferral due to hypohemoglobinemia in blood donorsGCST901041130.39
5546Lysoalkylphosphatidylcholine (O-24:2) levelsGCST900254380.39
5547CTBS levelsGCST904689000.39
5548StrokeGCST0069060.39
5549Triglycerides to Total Lipids in Medium VLDL percentageGCST904990690.39
5550CLEC1A levelsGCST904242310.39
5551rfMRI amplitudes (ICA100 node 45)GCST900046330.39
5552Biological Sibling: High cholesterolGCST904763710.39
5553Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T352ECGA0003520.39
5554Plasma 1-arachidonoyl-GPE (20:4n6)* levels in chronic kidney diseaseGCST902642070.39
5555Haddock likingGCST900947760.39
5556HS6ST1/MEGF9 ratioGCST903150810.39
5557Triglycerides in large HDLGCST904978820.39
5558CA6/DNER ratioGCST903135940.39
5559MANF/NCK2 ratioGCST903153590.39
5560PDGFA/PRSS27 ratioGCST903156160.39
5561CD80 levelsGCST904686500.39
5562aparc-a2009s rh area G-occipital-supGCST900033900.39
5563Cardiorespiratory fitness slopeGCST900933200.39
5564CTSD levelsGCST904689100.39
5565MAVS/SCAMP3 ratioGCST903153960.39
5566Sphinganine-1-phosphate levelsGCST901998450.39
5567IDP dMRI TBSS OD Tapetum RGCST900044480.39
5568AKT1S1/TDRKH ratioGCST903132330.39
5569Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T376ECGA0003760.39
5570NUDT16 levelsGCST904701050.39
5571Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T229ECGU0002290.39
5572NCK2 levelsGCST904700070.39
5573monocyte (fraction, maximum, inv-norm transformed)GCST904755080.39
5574CD46/TIMP1 ratioGCST903138370.39
5575Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T134ECGA0001340.39
5576GLB1/PCSK9 ratioGCST903149330.39
5577Free cholesterol to total lipids in chylomicrons and extremely large VLDL percentage (UKB data field 23582)GCST902696790.39
5578Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T493ECGU0004930.39
5579Hemoglobin concentration varianceGCST905656850.39
5580Free cholesterol to total lipids in large HDL percentage (UKB data field 23637)GCST902697340.39
5581Principal component-derived dietary pattern 46GCST901330510.39
5582YES1 levelsGCST904710880.39
5583Free Cholesterol to Total Lipids in Medium VLDL percentageGCST904989760.39
5584Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T413ECGU0004130.38
5585COX5B levelsGCST904688340.38
5586CASP3/PDGFB ratioGCST903136380.38
5587ITGB1/REG1A ratioGCST903152280.38
5588Triglycerides in small LDLGCST904997220.38
5589Facial pigmentation measurement (UV light)GCST900022830.38
5590CALCOCO1/CRACR2A ratioGCST903135980.38
5591Cholesterol levels in very large HDLGCST905003100.38
5592Allergic rhinitisGCST900860420.38
5593Arachidoylcarnitine (C20) levelsGCST902001350.38
5594Cholesteryl Esters in Medium VLDLGCST904989390.38
5595Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T287ECGU0002870.38
5596VEGFA levelsGCST904710340.38
5597IDP dMRI TBSS L3 Cingulum hippocampus LGCST900042080.38
5598DVT of lower extremitiesFING000004820.38
5599Leg fat percentage (right) | Impedance measuresUKBB000003920.38
5600Emotional abuseGCST905518450.38
5601Cholesteryl Esters to Total Lipids in Large HDL percentageGCST904977680.38
5602MGLL levelsGCST904699010.38
5603CELA3A/KIRREL2 ratioGCST903140130.38
5604IDP dMRI TBSS FA External capsule LGCST900039100.38
5605JAM2/TNFRSF19 ratioGCST903152410.38
5606Blood cell traits latent factor 5 (platelet)GCST905592470.38
5607Phospholipids in small LDLGCST904996810.38
5608Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T491ECGA0004910.38
5609Triglycerides to total lipids in medium HDL percentage (UKB data field 23643)GCST902697400.38
5610Renal failureFING000012500.38
5611CD84/DKK1 ratioGCST903139110.38
5612T1 FIRST volume R PutaGCST903839950.38
5613Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T487ECGU0004870.38
5614CXCL16/NOTCH1 ratioGCST903143390.38
5615CASP10/PRTFDC1 ratioGCST903136270.38
5616Free cholesterol levels in very large VLDLGCST900930200.38
5617PDGFA levelsGCST904701880.38
5618Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T293ECGA0002930.38
5619IGFBP1 levelsGCST904695270.38
5620Phospholipid levels in HDLGCST900928270.38
5621Concentration of medium HDL particlesGCST904986220.38
5622Thick vs thin eyebrowsGCST0060930.38
5623Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T442ECGA0004420.38
5624PRSS27 levelsGCST904703420.38
5625SPINK6 levelsGCST904707250.38
5626BMP6 levelsGCST904684540.38
5627DTI autoptx L2 fmi tractGCST903851770.38
5628aparc-a2009s rh area S-parieto-occipitalGCST900034350.38
5629Takes medication for acid reflux/GERD?GCST904753210.38
5630Tachycardia NOS (PheCode 427.7)GCST904759790.38
5631IDP dMRI ProbtrackX ICVF slf lGCST900043960.38
5632Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T356ECGA0003560.38
5633Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T496ECGU0004960.38
5634Cholesteryl ester levels in small HDLGCST900929460.37
5635ADIPOQ levelsGCST904682450.37
5636Linoleic acid to total fatty acids percentageGCST905023210.37
5637Omega-3 fatty acids to Omega-6 fatty acids ratioGCST905023980.37
5638F11R/PLXNA4 ratioGCST903147240.37
5639ERBIN/SNAP29 ratioGCST903146970.37
5640BA-exvivo rh volume V2GCST900028590.37
5641HPCAL1 levelsGCST904694710.37
5642Diabetes (confirmatory factor analysis Factor 28)GCST903093620.37
5643aparc-pial rh area fusiformGCST900031800.37
5644Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T445ECGA0004450.37
5645Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T191ECGU0001910.37
5646CX3CL1/RGMB ratioGCST903143270.37
5647CHMP1A levelsGCST906190020.37
5648Dermatomycosis (PheCode 110.2)GCST904755650.37
5649Average diameter for HDL particlesGCST904974460.37
5650SVEP1 levelsGCST902429280.37
5651Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T486ECGU0004860.37
5652PCBD1 levelsGCST904701660.37
5653ADGRG2/ITGB1 ratioGCST903131850.37
5654Free cholesterol to total lipids in medium LDL percentage (UKB data field 23622)GCST902697190.37
5655Diastolic blood pressureGCST900187320.37
5656Cholesterol levels in chylomicrons and extremely large VLDLGCST905009050.37
5657PDGFRB levelsGCST904701920.37
5658Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T213ECGA0002130.37
5659IDP SWI T2star left putamenGCST900038670.37
5660Concentration of very large HDL particlesGCST900930110.37
5661CA12 levelsGCST904685070.37
5662Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T225ECGA0002250.37
5663GonarthrosisFING000005850.37
5664PSIP1 levelsGCST904703540.37
5665Cancer (UKB data field 2453)GCST900436280.37
5666Diseases of esophagus (PheCode 530)GCST904760450.37
5667Concentration of large HDL particlesGCST904978360.37
5668CSTB levelsGCST901792720.37
5669Medication for pain relief, constipation, heartburn - Ibuprofen (e.g. Nurofen) | MedicationUKBB000004550.37
5670Triacylglycerol_56:5_[M+NH4]1+ levelsGCST900605540.37
5671IGFBP2 levelsGCST904695280.37
5672Major dietary changes in the last 5 years - Yes, because of other reasons | DietUKBB000004230.37
5673LILRB1 levelsGCST904697760.37
5674IZUMO4 levelsGCST904237920.37
5675Monounsaturated fatty acid levelsGCST905023470.37
5676DTI autoptx L2 atr r tractGCST903851690.37
5677PCDH17/ROBO1 ratioGCST903156040.37
5678CDKN1A/DAB2 ratioGCST903139670.37
5679Androstenediol (3beta,17beta) disulfate (2) levelsGCST901998510.37
5680ICOSLG levelsGCST904695030.37
5681CTSC levelsGCST904689090.37
5682Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T411ECGU0004110.37
5683Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T75ECGA0000750.37
5684ESAM/SCARF1 ratioGCST903147150.37
5685Reticulocyte countGCST0046220.37
5686Phospholipid levels in large VLDLGCST900928760.37
5687Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T464ECGU0004640.37
5688NECTIN2/VSIR ratioGCST903155330.36
5689Right-hemisphere salience/ventral attention network to hippocampus white-matter structural connectivityGCST903028210.36
5690wg lh intensity-contrast superiorparietalGCST900038200.36
5691FABP1/SULT2A1 ratioGCST903147550.36
5692Omega-3 fatty acid levelsGCST905024400.36
5693Principal component-derived dietary pattern 39GCST901330440.36
5694Age started wearing glasses (UKB data field 2217)GCST904681560.36
5695Cholesterol levels in large VLDLGCST900928680.36
5696Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T145ECGU0001450.36
5697Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T295ECGA0002950.36
5698IDP dMRI TBSS ICVF Cingulum cingulate gyrus LGCST900043620.36
5699Certain disorders involving the immune mechanismFING000002640.36
5700MET levelsGCST904698950.36
5701IDP dMRI TBSS L1 Retrolenticular part of internal capsule LGCST900040960.36
5702Operative procedures - Fibreoptic endoscopic examination of upper gastrointestinal tract and biopsy of lesion of upper gastrointestinal tract | Summary OperationsUKBB000005780.36
5703Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T342ECGA0003420.36
5704HPCAL1/LAT ratioGCST903150720.36
5705Cholesteryl Esters in Small HDLGCST904993860.36
5706ANPEP/CXADR ratioGCST903132720.36
5707DTI autoptx MD slf r tractGCST903852420.36
5708IGF2R levelsGCST904695260.36
5709Placental weight (fetal genotype, adjusted for sex)GCST902751970.36
5710Ischemic strokeGCST0069080.36
5711Total fatty acid levelsGCST905000530.36
5712Lactosyl-N-nervonoyl-sphingosine (d18:1/24:1) levelsGCST902000980.36
5713Hair colour (natural, before greying) - Black | Sun exposureUKBB000002950.36
5714Primary/intrinsic cardiomyopathies (PheCode 425.1)GCST904759510.36
5715Plantar fascial fibromatosisFING000011690.36
5716SEMA4D/TXNDC5 ratioGCST903158240.36
5717Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T124ECGA0001240.36
5718KLK8/WFDC12 ratioGCST903152590.36
5719AARSD1/UBAC1 ratioGCST903131350.36
5720LRRC59 levelsGCST904698040.36
5721HDL cholesterolGCST0007550.36
5722Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T132ECGU0001320.36
5723Phospholipids in very large HDL (UKB data field 23553)GCST902696500.36
5724Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T372ECGA0003720.36
5725DAG1/DKK1 ratioGCST903143730.36
5726Cholesterol to total lipids in small LDL percentage (UKB data field 23625)GCST902697220.36
5727Cholesterol levels in small HDLGCST900929440.36
5728DNAJB2 levelsGCST904690130.36
5729aparc-Desikan rh area parstriangularisGCST900031260.36
5730wg lh intensity-contrast frontalpoleGCST900038230.36
5731Concentration of very small VLDL particlesGCST905008190.36
5732Neutrophil countGCST900023520.36
5733Father's age | Family historyUKBB000002400.36
5734OLR1 levelsGCST904701220.36
5735aparc-a2009s rh volume G-cingul-Post-ventralGCST900030080.36
5736CCL4 levelsGCST900120520.36
5737Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T195ECGU0001950.36
5738APP levelsGCST904683440.36
5739GABARAPL1 levelsGCST904692870.36
5740Saturated fatty acids to total fatty acids percentageGCST905026850.36
5741GERD (PheCode 530.11)GCST904760470.36
5742Rubneribacter sp002159915 abundance in stoolGCST900325410.36
5743Cholesterol to total lipids ratio in very large HDLGCST900930050.36
5744CD40/ITGB5 ratioGCST903138160.36
5745Left-hemisphere limbic network to right-hemisphere salience/ventral attention network white-matter structural connectivityGCST903027320.35
5746Pain in thoracic spineFING000011390.35
57473-hydroxybutyrate levels (UKB data field 23474)GCST902695710.35
5748IDP T1 SIENAX white normalised volumeGCST900024320.35
5749Alzheimer's disease (MTAG)GCST904490530.35
5750Triglycerides in VLDLGCST905003040.35
5751DEFA1_DEFA1B/LCN2 ratioGCST903144540.35
5752Sphingomyelin_38:2_[M+H]1+ levelsGCST900603020.35
5753Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T296ECGA0002960.35
5754Volume of right anterior amygdaloid areaGCST904749040.35
5755GSTT2 levelsGCST900866520.35
5756Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T122ECGA0001220.35
5757Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T410ECGU0004100.35
5758Volume of left whole amygdalaGCST904749860.35
5759Medication for pain relief, constipation, heartburn - None of the above | MedicationUKBB000004570.35
5760Total lipids in very large HDL (UKB data field 23552)GCST902696490.35
5761IDP dMRI TBSS ICVF Genu of corpus callosumGCST900043290.35
5762CSNK1G2 levelsGCST902406080.35
5763APP/DAG1 ratioGCST903133200.35
5764Alkenylphosphatidylethanolamine (P-20:0/18:2) levelsGCST900256830.35
5765T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 71)GCST903206340.35
5766ANGPTL1 levelsGCST904683020.35
5767Cholesteryl Esters to Total Lipids in Medium HDL percentageGCST904985500.35
5768APRT levelsGCST904683450.35
5769F9/FURIN ratioGCST903147470.35
5770UrticariaGCST900187160.35
5771EREG/F2R ratioGCST903147000.35
5772Spread type: Butter and margarine vs never use spread (UKB data field 1428)GCST901329480.35
5773Left-hemisphere somatomotor network to right-hemisphere salience/ventral attention network white-matter structural connectivityGCST903026780.35
5774Phosphatidylethanolamine_35:2_[M-H]1- levelsGCST900602600.35
5775CXADR levelsGCST904689220.35
5776DPP7 levelsGCST904690350.35
5777GLB1 levelsGCST904693550.35
5778Deep vein thrombosis [DVT] (PheCode 452.2)GCST904760100.35
5779LACRT levelsGCST904697250.35
5780GOLGA3 levelsGCST904693750.35
5781GoutGCST903997000.35
5782Omega-3 fatty acid levelsGCST905020640.35
5783NPTX1 levelsGCST904700780.35
5784Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T375ECGA0003750.35
5785Triacylglycerol_53:2_[M+NH4]1+ levelsGCST900605310.35
5786Diacylglycerol_33:1_[M+H-H2O]1+ levelsGCST900601730.35
5787Type 1 diabetes with ophthalmic manifestations (PheCode 250.13)GCST904756630.35
5788DPY30 levelsGCST904690370.35
5789ARSB levelsGCST904683690.35
5790IDUA levelsGCST904695080.35
5791Urine X-23518 levels in chronic kidney diseaseGCST902665950.35
5792Volume of right medial nucleusGCST904749250.35
5793Cholesteryl Esters in Large HDLGCST904977530.35
5794ODAM levelsGCST904701150.35
5795PLA2G7 levelsGCST904702490.35
5796KLK14 levelsGCST904274280.35
5797IDP T1 SIENAX white unnormalised volumeGCST900024330.35
5798CCL15 levelsGCST904685670.35
5799Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T495ECGA0004950.35
5800CD59 levelsGCST904686390.35
5801ATP5IF1/DECR1 ratioGCST903133820.35
5802TDP1 levelsGCST904708260.35
5803T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 111)GCST903206740.35
5804Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T196ECGU0001960.35
5805METAP1D levelsGCST904698920.35
5806Malignant neoplasm of bladder (PheCode 189.21)GCST904755990.34
5807Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T85ECGU0000850.34
5808Butternut squash likingGCST900947180.34
5809X-04499--3,4-dihydroxybutyrate levelsGCST902434970.34
5810CKMT1A or CKMT1B levelsGCST904687600.34
5811DDR1/SFTPD ratioGCST903144430.34
5812Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T290ECGA0002900.34
5813Principal component-derived dietary pattern 58GCST901330610.34
5814Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T97ECGA0000970.34
5815Total testosterone levelsGCST905033130.34
5816Systolic blood pressureGCST902786420.34
5817VPS53 levelsGCST904710480.34
5818HEXIM1/TBL1X ratioGCST903150530.34
5819Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T487ECGA0004870.34
5820CD38/IL12A_IL12B ratioGCST903138080.34
5821Other extrapyramidal and movement disorders in other diseasesFING000010470.34
5822Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T62ECGA0000620.34
5823Triglycerides in large VLDLGCST904982670.34
5824Left ventricular end diastole anterolateral wall thicknessGCST902785170.34
5825Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T373ECGA0003730.34
5826CASP8/PRDX6 ratioGCST903136550.34
5827SIRT2/STAT5B ratioGCST903158460.34
5828DTI autoptx FA ilf l tractGCST903851260.34
5829T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 111)GCST903209300.34
5830Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T443ECGA0004430.34
5831Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T80ECGA0000800.34
5832DTI TBSS FA Posterior thalamic radiation LGCST903844090.34
5833T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 74)GCST903206370.34
5834LPL levelsGCST904697880.34
5835Total lipids in small HDLGCST904994560.34
5836SOD2 levelsGCST904707050.34
5837Takes medication for Sleep apnea?GCST904752580.34
5838EREG/TIMP3 ratioGCST903147080.34
5839T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 78)GCST903206410.34
5840Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T131ECGA0001310.34
5841ESYT2 levelsGCST904691560.34
5842Retinal detachments and defects (PheCode 361)GCST904758450.34
5843Phospholipids to Total Lipids in Small HDL percentageGCST904995050.34
5844SarcoidosisGCST900186980.34
5845Phosphate levelsGCST902003930.34
5846ENO2/PLXNA4 ratioGCST903146650.34
5847Other infective otitis externaFING000010600.34
5848GZMA/TNFRSF4 ratioGCST903150130.34
5849Total lipids in small HDLGCST904994430.34
5850Plasma 4-guanidinobutanoate levels in chronic kidney diseaseGCST902646200.34
5851Omega-3 fatty acids to total fatty acids percentageGCST904991630.34
5852EREG/MPI ratioGCST903147050.34
5853T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 45)GCST903208640.34
5854T1 FreeSurfer aseg Left-Lateral-VentricleGCST903841390.34
5855Right-hemisphere visual network to right-hemisphere default mode network white-matter structural connectivityGCST903027800.34
5856Cholesteryl Esters in Small HDLGCST904993820.34
5857Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T361ECGA0003610.34
5858SDK2 levelsGCST904705620.34
5859Deviated nasal septumFING000004090.34
5860Seminoma of testis, excluding all cancers (controls excluding all cancers)FING000012890.34
5861Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T71ECGA0000710.34
5862Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T348ECGA0003480.34
5863DCBLD2/PLA2G15 ratioGCST903144280.34
5864Left-hemisphere somatomotor network to right-hemisphere dorsal attention network white-matter structural connectivityGCST903026770.34
5865CXCL10 levelsGCST904689230.33
5866Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T84ECGU0000840.33
5867Triglycerides to total lipids in large HDL percentage (UKB data field 23638)GCST902697350.33
5868CSNK2A1 levelsGCST904688890.33
5869Cholesterol levels in very small VLDLGCST905007000.33
5870Principal component-derived dietary pattern 26GCST901330310.33
5871Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T242ECGA0002420.33
5872pro-brain natriuretic peptide (proBNP, mean, inv-norm transformed)GCST904763120.33
5873Histidine levelsGCST904974810.33
5874Omega-3 fatty acids to total fatty acids percentageGCST905024510.33
5875CD244 levelsGCST902747710.33
5876Chronic obstructive pulmonary disease in current smokersGCST900165930.33
5877LTBR levelsGCST904698160.33
5878Triacylglycerol_56:7_[M+NH4]1+ levelsGCST900605510.33
5879Free cholesterol levels in HDLGCST900928240.33
5880Acquired toe deformities (PheCode 735.2)GCST904762490.33
5881LCN2/S100A12 ratioGCST903153090.33
5882Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T374ECGA0003740.33
5883PPL levelsGCST904702940.33
5884Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T342ECGU0003420.33
5885PFKM levelsGCST906188020.33
5886Myocardial fractal dimension (slice 6)GCST900002920.33
5887T1 FreeSurfer aseg Right-choroid-plexusGCST903841700.33
5888Free cholesterol to total lipids in large VLDL percentage (UKB data field 23592)GCST902696890.33
5889SarcoidosisFING000012750.33
5890Anomalies of dental arch relationship, including avohilmoFING000000910.33
5891wg lh intensity-contrast parahippocampalGCST900038070.33
5892TMEM25 levelsGCST904708880.33
5893CD58/MEGF10 ratioGCST903138530.33
5894NECTIN4 levelsGCST904700210.33
5895Neuroendocrine tumor and carcinoma of pancreas, excluding all cancers (controls excluding all cancers)FING000008640.33
5896CD248 levelsGCST904686120.33
5897FABP5/PPCDC ratioGCST903147630.33
5898KHK levelsGCST904696750.33
5899T1 FreeSurfer DK lh precentral thicknessGCST903856450.33
5900Cholesteryl Esters to Total Lipids in Large VLDL percentageGCST904981620.33
5901HEXIM1 levelsGCST904694470.33
5902Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T56ECGA0000560.33
5903Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T467ECGU0004670.33
5904NH4_C22:4 Cholesteryl ester levels in chronic kidney diseaseGCST902572270.33
5905Omega-3 fatty acids to Omega-6 fatty acids ratioGCST905024100.32
5906Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T446ECGA0004460.32
5907Infantile hypertrophic pyloric stenosisGCST0067050.32
5908Plasma X-26054 levels in chronic kidney diseaseGCST902668580.32
5909Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T294ECGA0002940.32
5910GPC1/ITGB6 ratioGCST903149770.32
5911GLOD4/HSPA1A ratioGCST903149370.32
5912X-23641 levelsGCST902006030.32
5913CSF3R levelsGCST904688850.32
5914IDP dMRI ProbtrackX L1 slf rGCST900042680.32
5915Right-hemisphere somatomotor network to caudate white-matter structural connectivityGCST903027950.32
5916Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T227ECGU0002270.32
5917AXIN1/HEXIM1 ratioGCST903134080.32
5918F-sauces liking (derived food-liking factor)GCST900948310.32
5919Oral glucose tolerance test-1hGCST902977890.32
5920LAT2/SDC4 ratioGCST903152780.32
5921AIFM1/SIRT2 ratioGCST903132210.32
5922T1 FreeSurfer DK rh cuneus volumeGCST903857610.32
5923hemoglobin (mean, inv-norm transformed)GCST904753740.32
5924NBL1 levelsGCST904700010.32
5925LRTM2 levelsGCST904698080.32
5926Triglycerides to Total Lipids in Large HDL percentageGCST904978960.32
5927CFHR1 levelsGCST906185030.32
5928Colorectal cancerGCST900185880.32
5929SIRPA levelsGCST904706390.32
5930IDP dMRI TBSS OD External capsule RGCST900044340.32
5931NeuroticismGCST0052320.32
5932Biliverdin levels in chronic kidney diseaseGCST902574950.32
5933VEGFB levelsGCST904710350.32
5934PLA2G2A levelsGCST904702470.32
5935SIAE levelsGCST904706290.32
5936Left-hemisphere default mode network to right-hemisphere control network white-matter structural connectivityGCST903027650.32
5937Radial styloid tenosynovitis [de Quervain]FING000012370.32
5938HRG levelsGCST904694760.32
5939CXCL11 levelsGCST902747810.32
5940Treatment or medication use - rosuvastatin (UKB data field 20003_1141192410)GCST900425390.32
5941CDC42BPB levelsGCST904686660.32
5942Plum likingGCST900948120.32
5943rfMRI amplitudes (ICA100 node 15)GCST900046030.32
5944NTRK3/SCARF2 ratioGCST903155710.32
5945Otitis externa, unspecifiedFING000011290.32
5946Phenylalanine levels (UKB data field 23468)GCST902695650.32
5947Docosahexaenoic acid to total fatty acids percentageGCST905019970.32
5948Bicuspidal aortic valve syndromeFING000002120.32
5949Childhood maltreatmentGCST905518320.32
5950CCL11/CCL13 ratioGCST903136710.32
5951APOB/APOA1 ratioGCST902695380.32
5952Free cholesterol in very small VLDLGCST905007740.32
5953CD99/RELT ratioGCST903139300.32
5954Triglycerides to total lipids ratio in large HDLGCST900928550.32
5955MTHFSD levelsGCST904699560.32
5956CD84/VASH1 ratioGCST903139200.32
5957BDNF levelsGCST904684370.32
5958FKBP4 levelsGCST904692430.32
5959Pulmonary embolismFING000012280.31
5960Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T79ECGA0000790.31
5961Phospholipids in very small VLDLGCST905008400.31
5962MYOC/RGMB ratioGCST903155080.31
5963Arthropathy in ulcerative colitisFING000001100.31
5964Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T471ECGU0004710.31
5965TF levelsGCST904708410.31
5966IDP T1 FAST ROIs L cerebellum VIGCST900025660.31
5967Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T139ECGU0001390.31
5968Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T344ECGA0003440.31
5969IDP dMRI TBSS MO Medial lemniscus LGCST900039610.31
5970HEPH levelsGCST904694460.31
5971Whole body fat free mass (UKB data field 23101)GCST904281200.31
5972FAM20A levelsGCST904691850.31
5973Phospholipids in small HDLGCST904994780.31
5974Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T362ECGA0003620.31
5975COX5B/METAP1D ratioGCST903142010.31
5976LAMA4/PDGFB ratioGCST903152730.31
5977CXCL8 levelsGCST904689340.31
5978PITHD1 levelsGCST904702390.31
5979Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T306ECGA0003060.31
5980MYH9 levelsGCST904699750.31
5981Cholesteryl ester levels in very large HDLGCST900930060.31
5982IDP dMRI TBSS L2 Posterior limb of internal capsule LGCST900041420.31
5983Platelet countGCST900187490.31
5984CRKL/DBNL ratioGCST903142630.31
5985Behaviour of cancer tumour: malignant, primary site, PHESANT recoding (UKB data field 40012_3)GCST900439460.31
5986Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T292ECGU0002920.31
5987Total lipids in medium HDLGCST904986040.31
5988CEP43/PLXNB3 ratioGCST903140200.31
5989NME3 levelsGCST904700550.31
5990Telomere length (principal component 2)GCST904351450.31
5991NUDT5 levelsGCST904701070.31
5992IL6ST/PDGFRA ratioGCST903151690.31
5993Belief that own life is meaningful | Happiness and subjective well-beingUKBB000000900.31
5994ICD10 C50.9: Malignant neoplasm of breast of unspecified siteGCST900438890.31
5995ICD10 N91.0, N91.1, N91.2: Amenorrhea, including primary amenorrhea, secondary amenorrhea and unspecified amenorrheaGCST904542190.31
5996CRYBB2 levelsGCST904688750.31
5997Esophagitis, GERD and related diseases (PheCode 530.1)GCST904760460.31
5998RLN2 levelsGCST904704740.31
5999Main speciality of consultant (recoded) - General surgery | Summary AdministrationUKBB000004170.31
6000Volume of left anterior amygdaloid areaGCST904749370.31